Showing results (71-80 of 461) with videos related to
Sort By:
Pageof 47
Cancer|November 15, 1982
Clinical and immunological correlates of leukemia cutis in childhoodN L Dunn, N B McWilliams, T MohanakumarBlood|September 1, 1976
Human acute myelomonocytic leukemia: serologic studies with simian antiseraT Mohanakumar, D S Miller, R S MetzgarAnnals of Plastic Surgery|November 1, 2005
Combined treatment with CD40 costimulation blockade, T-cell depletion, low-dose irradiation, and donor bone marrow transfusion in limb allograft survivalThomas H Tung, Susan E Mackinnon, T MohanakumarImmunologic Research|August 18, 2005
Molecular mechanisms of chronic rejection following transplantationElbert Kuo, Takahiro Maruyama, Felix Fernandez, et al.Clinical Transplants|August 7, 2014
Role of alloimmunity and autoimmunity in allograft rejectionBabak Banan, Zhongping Xu, Muthukumar Gunasekaran, et al.Cancer Chemotherapy and Pharmacology|August 24, 1999
Anticancer effect of 9-nitrocamptothecin liposome aerosol on human cancer xenografts in nude miceV Knight, N V Koshkina, J C Waldrep, et al.The Journal of Gene Medicine|March 30, 2000
Gene transfer by guanidinium-cholesterol: dioleoylphosphatidyl-ethanolamine liposome-DNA complexes in aerosolC L Densmore, T H Giddings, J C Waldrep, et al.European Journal of Immunology|July 20, 2004
Pre-exposure to sub-saturating concentrations of HLA class I antibodies confers resistance to endothelial cells against antibody complement-mediated lysis by regulating Bad through the phosphatidylinositol 3-kinase/Akt pathwayKishore Narayanan, Andrés Jaramillo, Donna L Phelan, et al.Molecular Immunology|June 1, 1993
CD32C (Fc gamma RIIC) mRNA expression and regulationY G Alevy, J Tucker, B Naziruddin, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1992
Evidence for cross-regulation of Fc gamma RIIIB (CD16) receptor-mediated signaling by Fc gamma RII (CD32) expressed on polymorphonuclear neutrophilsB Naziruddin, B F Duffy, J Tucker, et al.Pageof 47